1-8 of 8
Richard F. Schlenk, M.D.
Close
Sort by
Journal Articles

Analysis of the ETS Family Member Genes ERG, ETS2, ETS1 and FLI1 in Acute Myeloid Leukemia (AML) Patients with Normal Cytogenetics: Expression Levels and Impact On Clinical Outcome. A Study of the AMLSG.

Verena I. Gaidzik, M.D., Cailian Wang, M.D., Richard F. Schlenk, M.D., Lars Bullinger, M.D., Peter Paschka, M.D., Frank G. Rücker, M.D., Andrea Corbacioglu, Ph.D., Karina Eiwen, Jürgen Krauter, M.D., Brigitte Schlegelberger, MD, Arnold Ganser, M.D., Manuela Zucknick, Ph.D., Axel Benner, M.Sc., Hartmut Döhner, M.D., Konstanze Döhner, M.D.
Journal: Blood
Blood (2009) 114 (22): 1600.
https://doi.org/10.1182/blood.V114.22.1600.1600
Published: 2009
Journal Articles

In Acute Myeloid Leukemia with Complex Karyotype TP53 Alterations Are Associated with Specific Genomic Aberrations and Predict Inferior Survival.

Frank G Rücker, M.D., Richard F Schlenk, M.D., Lars Bullinger, M.D., Helena Kett, Annegret Becker, Carla-Maria Kugler, Thorsten Zenz, MD, Peter Lichter, Ph.D., Jürgen Krauter, M.D., Brigitte Schlegelberger, M.D., Arnold Ganser, M.D., Hartmut Döhner, M.D., Konstanze Döhner, M.D.
Journal: Blood
Blood (2009) 114 (22): 2632.
https://doi.org/10.1182/blood.V114.22.2632.2632
Published: 2009
Journal Articles

Type and Number of Secondary Molecular Lesions Improve Outcome Prediction in Acute Myeloid Leukemia (AML) with inv(16) or t(16;16): A Study of the German-Austrian AML Study Group (AMLSG).

Peter Paschka, M.D., Juan Du, M.D., Richard F. Schlenk, M.D., Verena I. Gaidzik, M.D., Lars Bullinger, M.D., Andrea Corbacioglu, Ph.D., Manuela Zucknick, Ph.D., Axel Benner, M.Sc., Frank Stegelmann, M.D., Daniela Späth, Sabine Kayser, M.D., Brigitte Schlegelberger, M.D., Jürgen Krauter, M.D., Arnold Ganser, M.D., Hartmut Döhner, M.D., Konstanze Döhner, M.D.
Journal: Blood
Blood (2009) 114 (22): 824.
https://doi.org/10.1182/blood.V114.22.824.824
Published: 2009
Journal Articles

Mutations in the Fms-Related Tyrosine Kinase 3 (FLT3) Gene Independently Predict Poor Outcome in Acute Myeloid Leukemia (AML) with t(8;21): A Study of the German-Austrian AML Study Group (AMLSG).

Peter Paschka, M.D., Juan Du, M.D., Richard F. Schlenk, M.D., Lars Bullinger, M.D., Verena I. Gaidzik, M.D., Andrea Corbacioglu, Ph.D., Axel Benner, M.Sc., Manuela Zucknick, Ph.D., Frank Stegelmann, M.D., Daniela Späth, Sabine Kayser, M.D., Brigitte Schlegelberger, MD, Juergen Krauter, M.D., Arnold Ganser, M.D., Hartmut Döhner, Konstanze Döhner
Journal: Blood
Blood (2009) 114 (22): 825.
https://doi.org/10.1182/blood.V114.22.825.825
Published: 2009
Journal Articles

Aberrant Expression of the Homeobox Gene CDX2 in Acute Myeloid Leukemia.

Claudia Scholl, MD, Dimple Bansal, Ph.D., Konstanze Dohner, M.D., Karina Eiwen, Benjamin H. Lee, M.D., Ph.D., Frank G. Rucker, M.D., Richard F. Schlenk, M.D., Lars Bullinger, M.D., Hartmut Dohner, M.D., D. Gary Gilliland, M.D., Ph.D., Stefan Frohling, M.D.
Journal: Blood
Blood (2006) 108 (11): 8.
https://doi.org/10.1182/blood.V108.11.8.8
Published: 2006
Journal Articles

Detection of RAS, KIT and FLT3 Gene Mutations in t(8;21)-Positive Acute Myeloid Leukemia (AML): Evaluation of the Clinical Relevance.

Juan Du, Richard F. Schlenk, M.D., Andrea Corbacioglu, Ph.D., Marianne Habdank, Claudia Scholl, M.D., Stefan Frohling, M.D., Lars Bullinger, M.D., Arnold Ganser, M.D., Hartmut Dohner, M.D., Konstanze Dohner, M.D.
Journal: Blood
Blood (2006) 108 (11): 2301.
https://doi.org/10.1182/blood.V108.11.2301.2301
Published: 2006
Journal Articles

RAS, KIT and FLT3 Gene Mutations in inv(16)/t(16;16)-Positive Acute Myeloid Leukemia (AML): Incidence and Relevance on Clinical Outcome.

Juan Du, Richard F. Schlenk, M.D., Andrea Corbacioglu, Ph.D., Marianne Habdank, Claudia Scholl, M.D., Stefan Frohling, M.D., Lars Bullinger, M.D., Arnold Ganser, M.D., Hartmut Dohner, M.D., Konstanze Dohner, M.D.
Journal: Blood
Blood (2006) 108 (11): 2303.
https://doi.org/10.1182/blood.V108.11.2303.2303
Published: 2006
Journal Articles

Acute Myeloid Leukemia with Deletion 9q Is Associated with CEBPA Loss-of-Function Mutations.

Stefan Frohling, M.D., Richard F. Schlenk, M.D., Jurgen Krauter, M.D., Arnold Ganser, M.D., Christian Thiede, M.D., Gerhard Ehninger, M.D., Detlef Haase, M.D., Lana Harder, M.D., Claudia Scholl, M.D., Michael A. Caligiuri, M.D., Clara D. Bloomfield, M.D., Hartmut Dohner, M.D., Konstanze Dohner, M.D.
Journal: Blood
Blood (2004) 104 (11): 2896.
https://doi.org/10.1182/blood.V104.11.2896.2896
Published: 2004